Erratum


Headache Volume 46 Supplement 4 featured several omissions.

The title of the supplement is: Dihydroergotamine in the Treatment of Migraine: Past, Present

and Future

The supplement was edited by: Joel R. Saper, MD

The sponsor of the supplement, though identified by their logo on the Table of Contents, was not correctly identified on the cover of the supplement. The sponsor was Valeant Pharmaceuticals International.

The following author disclosures should also have been included in the supplement:

Fred Freitag, DO

Grants received/research conducted:

Advanced Bionics, Alzyer, AstraZeneca, Capnia, GlaxoSmithKline, Johnson and Johnson, Merck and Co., Ortho-McNeil Pharmaceuticals, Ortho-McNeil Neurologics, Solvay and Vernalis

Consultant/Advisory Board Member:

Allergan, AstraZeneca, Capnia, Endo, Merck and Co., Ortho-McNeil Neurologics and Valeant Pharmaceuticals

Speaker's Bureau:

AstraZeneca, GlaxoSmithKline, Merck and Co., Ortho-McNeil Pharmaceuticals, Ortho-McNeil Neurologics, Pfizer and Valeant Pharmaceuticals

Equity interest:

None

Stephen Silberstein, MD

Grants received/research conducted:

Abbott, Advanced Bionics, AGA, Allergan, Advanced Neuro-Modulation System, AstraZeneca, Endo Pharmaceuticals, GlaxoSmithKline, Lilly, Medtronic, Merck, Ortho-McNeil, Pfizer, Pozen, ProEthic and Valeant Pharmaceuticals

Consultant/Advisory Board Member:

Allergan, Endo Pharmaceuticals, GlaxoSmithKline, Medtronic, Merck, Ortho-McNeil, Pfizer, Pozen and Valeant Pharmaceuticals

Speaker's Bureau:

AstraZeneca, GlaxoSmithKline, Merck, Ortho-McNeil, Pfizer

Joel Saper, MD

Has an equity interest in Pozen

David Dodick, MD

Grants received/research conducted:

National Institutes of Health, Mayo Clinic

Allergan, AstraZeneca, Alexza, Advanced Bionics, Medtronic, St Jude

Consultant/Advisory Board Member:

Allergan, Eli Lilly, GlaxoSmithKline, Medtronic, Merck & Co, Neuralieve, Ortho-McNeil Pharmaceutical, Pfizer Inc, Valeant Pharmaceuticals

Equity Interest:

None

Paul Winner, DO

Grants received/research conducted:

Allergan, Astra Zeneca, Easai, GlaxoSmithKline, Ortho-McNeil, Pfizer

Consultant/Advisory Board Member:

GlaxoSmithKline, Ortho-McNeil

Alan Rapoport, MD

Grants received/research conducted:

Allergan, AstraZeneca, Eisai Pharmaceuticals, Endo Pharmaceuticals, GlaxoSmithKline, Janssen Pharmaceuticals, Merck, Ortho-McNeil, Pfizer Inc., Pozen, UCB Pharma, Valeant, Winston Pharmaceuticals

Consultant/Advisory Board Member:

Allergan, AstraZeneca, Endo Pharmaceuticals, Express Scripts, Ortho-McNeil, Valeant

Speaker's Bureau:

Allergan, AstraZeneca, Endo Pharmaceuticals, GlaxoSmithKline, Merck, Ortho-McNeil, Pfizer Inc., Valeant

The journal has for some time requested the declaration of all conflicts of interest for manuscripts published in the regular issue. We have revised policies to ensure the full disclosure of interests for supplement articles moving forward.

Ancillary